Pharmaceutical

IO360 summit: CAR-T cell therapy applications beyond blood cancer

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment.

Apr 4, 2025 - 06:00
IO360 summit: CAR-T cell therapy applications beyond blood cancer
Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment.
Read the original article

Tags:

Previous Article

Atsena closes $150m in Series C round to progress gene therapy

Next Article

Pharma industry dodges tariff blow but still braces for disruption

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Novartis acquires Chinook for $3.2bn to boost kidney disease pipeline

Novartis acquires Chinook for $3.2bn to boost kidney di...

Aug 14, 2023

To prevent preeclampsia, experts push for broader blood pressure testing at home

To prevent preeclampsia, experts push for broader blood...

Apr 29, 2023

STAT+: Drugmakers already bet big on mRNA for cancer. Why is Biden going in, too?

STAT+: Drugmakers already bet big on mRNA for cancer. W...

Aug 25, 2023